Literature DB >> 28505676

[New Therapeutic Approaches in Inflammatory Diseases of the Eye - Targeting Lymphangiogenesis and Cellular Immunity: Research Unit FOR 2240 Presents Itself].

Claus Cursiefen1, Felix Bock1, Thomas Clahsen1, Birgit Regenfuss1, Andre Reis2, Philipp Steven1, Ludwig M Heindl1, Jacobus J Bosch3, Deniz Hos1, Sabine Eming4, Rafael Grajewski1, Arnd Heiligenhaus5, Sascha Fauser1, Jennifer Austin1, Thomas Langmann1.   

Abstract

Background Ophthalmology, principally, is a very successful subdiscipline in medicine. Nonetheless, there are still unmet medical needs which necessitate translational research. Methods The funding instrument of a Research Unit (RU) of the German Research Foundation (DFG) is presented as exemplified by the RU 2240 at the Department of Ophthalmology at the University of Cologne. Results The Research Unit integrates different research groups working on pathologic ocular inflammation, macrophages/microglia and (lymph)angiogenesis to collaborate in a synergistic way. Rotation positions allow young clinicians to rotate into research labs for a defined period of time. A Research Unit is also a powerful strategic tool to strengthen clinical and experimental ophthalmology at individual medical faculties. Conclusions The funding instrument of a Research Unit is highly suitable for fostering translational research in a medical subdiscipline such as ophthalmology, supporting the next generation of (clinician) scientists in ophthalmology and finding new cures for our patients. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28505676     DOI: 10.1055/s-0043-108247

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  1 in total

Review 1.  [Basic research in ophthalmology in Germany and its international context].

Authors:  U Schlötzer-Schrehardt; C Cursiefen
Journal:  Ophthalmologe       Date:  2017-09       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.